Clinical Trial Update: The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating venlafaxine for pain reduction after primary total knee replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Pain

Drugs mentioned

• Effexor XR (venlafaxine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Acute Pain, Chronic Pain | Phase 4 | Status: COMPLETED